FibroGen Inc
LSE:0IL8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
LSE:0IL8
|
US |
|
F
|
Fomento de Construcciones y Contratas SA
XBER:FCC
|
ES |
|
S
|
SLM Corp
XBER:SM1
|
US |
|
C
|
Cognizant Technology Solutions Corp
DUS:COZ
|
US |
|
C
|
Chefs' Warehouse Inc
SWB:2CF
|
US |
|
C
|
Coloplast A/S
SWB:CBHD
|
DK |
|
C
|
Currys PLC
F:CWB
|
UK |
|
Sunoco LP
NYSE:SUN
|
US |
|
Flughafen Zuerich AG
F:UZAA
|
CH |
|
T
|
Telstra Corporation Ltd
OTC:TTRAF
|
AU |
|
Agree Realty Corp
F:AGL
|
US |
|
M
|
M&G PLC
OTC:MGPUF
|
UK |
|
L
|
Lam Research Corp
XBER:LAR
|
US |
|
Abb Ltd
MIL:1ABB
|
CH |
|
Mizuho Financial Group Inc
TSE:8411
|
JP |
|
G
|
Greenyard NV
SWB:2P1
|
BE |
|
MERLIN Properties SOCIMI SA
OTC:MRPRF
|
ES |
|
R
|
Ralph Lauren Corp
XBER:PRL
|
US |
|
C
|
Cecep Costin New Materials Group Ltd
HKEX:2228
|
HK |
|
S
|
Seven & i Holdings Co Ltd
DUS:S6M
|
JP |
|
M
|
Metso Outotec Corp
F:M6Q
|
FI |
|
J
|
Jacobs Engineering Group Inc
F:JEG
|
US |
|
A
|
Allianz SE
MIL:ALV
|
DE |
|
T
|
Thales SA
DUS:CSF
|
FR |
Bankruptcy Probability
FibroGen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
FibroGen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
FibroGen Inc
NASDAQ:FGEN
|
32.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
379.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
FibroGen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, FibroGen Inc has total debt of 19.5m USD. This includes both short-term (0 USD) and long-term (19.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
